4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one

C138H146N46O4 — CID 158529003

IUPAC4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one
SMILESC=C(C)c1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.C=C(CCCNc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12)OC.CC(C)CC1CC(=O)N(c2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)C1.Cc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.Cn1nc(N2CC(C)(C3CC3)CC2=O)c2ccc(Nc3n[nH]c4ccccc34)cc21.Cn1nc(N2CC(C)(C3CC3)CC2=O)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(N2CCCCC2)c2ccc(Nc3n[nH]c4cccnc34)cc21
InChIInChI=1S/C23H24N6O.C22H23N7O.C22H25N7O.C20H23N7O.C19H21N7.C17H16N6.C15H14N6/c1-23(14-7-8-14)12-20(30)29(13-23)22-17-10-9-15(11-19(17)28(2)27-22)24-21-16-5-3-4-6-18(16)25-26-21;1-22(13-5-6-13)11-18(30)29(12-22)21-15-8-7-14(10-17(15)28(2)27-21)24-20-19-16(25-26-20)4-3-9-23-19;1-13(2)9-14-10-19(30)29(12-14)22-16-7-6-15(11-18(16)28(3)27-22)24-21-20-17(25-26-21)5-4-8-23-20;1-13(28-3)6-4-11-22-19-15-9-8-14(12-17(15)27(2)26-19)23-20-18-16(24-25-20)7-5-10-21-18;1-25-16-12-13(21-18-17-15(22-23-18)6-5-9-20-17)7-8-14(16)19(24-25)26-10-3-2-4-11-26;1-10(2)15-12-7-6-11(9-14(12)23(3)22-15)19-17-16-13(20-21-17)5-4-8-18-16;1-9-11-6-5-10(8-13(11)21(2)20-9)17-15-14-12(18-19-15)4-3-7-16-14/h3-6,9-11,14H,7-8,12-13H2,1-2H3,(H2,24,25,26);3-4,7-10,13H,5-6,11-12H2,1-2H3,(H2,24,25,26);4-8,11,13-14H,9-10,12H2,1-3H3,(H2,24,25,26);5,7-10,12H,1,4,6,11H2,2-3H3,(H,22,26)(H2,23,24,25);5-9,12H,2-4,10-11H2,1H3,(H2,21,22,23);4-9H,1H2,2-3H3,(H2,19,20,21);3-8H,1-2H3,(H2,17,18,19)
InChIKeyHNDDKPUNMVLOPY-UHFFFAOYSA-N
MW2513.00 g/mol
LogP26.11
Rot. Bonds29

About 4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one

4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one (PubChem CID 158529003) has the molecular formula C138H146N46O4 and a molecular weight of 2513.00 g/mol. Its IUPAC name is 4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one.

Molecular Properties

Compound Name4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one
PubChem CID158529003
Molecular FormulaC138H146N46O4
Molecular Weight2513.00 g/mol
Exact Mass2511.26
IUPAC Name4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one
SMILESC=C(C)c1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.C=C(CCCNc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12)OC.CC(C)CC1CC(=O)N(c2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)C1.Cc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.Cn1nc(N2CC(C)(C3CC3)CC2=O)c2ccc(Nc3n[nH]c4ccccc34)cc21.Cn1nc(N2CC(C)(C3CC3)CC2=O)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(N2CCCCC2)c2ccc(Nc3n[nH]c4cccnc34)cc21
InChIInChI=1S/C23H24N6O.C22H23N7O.C22H25N7O.C20H23N7O.C19H21N7.C17H16N6.C15H14N6/c1-23(14-7-8-14)12-20(30)29(13-23)22-17-10-9-15(11-19(17)28(2)27-22)24-21-16-5-3-4-6-18(16)25-26-21;1-22(13-5-6-13)11-18(30)29(12-22)21-15-8-7-14(10-17(15)28(2)27-21)24-20-19-16(25-26-20)4-3-9-23-19;1-13(2)9-14-10-19(30)29(12-14)22-16-7-6-15(11-18(16)28(3)27-22)24-21-20-17(25-26-21)5-4-8-23-20;1-13(28-3)6-4-11-22-19-15-9-8-14(12-17(15)27(2)26-19)23-20-18-16(24-25-20)7-5-10-21-18;1-25-16-12-13(21-18-17-15(22-23-18)6-5-9-20-17)7-8-14(16)19(24-25)26-10-3-2-4-11-26;1-10(2)15-12-7-6-11(9-14(12)23(3)22-15)19-17-16-13(20-21-17)5-4-8-18-16;1-9-11-6-5-10(8-13(11)21(2)20-9)17-15-14-12(18-19-15)4-3-7-16-14/h3-6,9-11,14H,7-8,12-13H2,1-2H3,(H2,24,25,26);3-4,7-10,13H,5-6,11-12H2,1-2H3,(H2,24,25,26);4-8,11,13-14H,9-10,12H2,1-3H3,(H2,24,25,26);5,7-10,12H,1,4,6,11H2,2-3H3,(H,22,26)(H2,23,24,25);5-9,12H,2-4,10-11H2,1H3,(H2,21,22,23);4-9H,1H2,2-3H3,(H2,19,20,21);3-8H,1-2H3,(H2,17,18,19)
InChIKeyHNDDKPUNMVLOPY-UHFFFAOYSA-N
XLogP26.11
TPSA572.48 Ų
H-Bond Donors15
H-Bond Acceptors40
Rotatable Bonds29
Heavy Atoms188
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002513.00
LogP ≤ 526.11
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1040

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one?
The IUPAC name of 4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one (CID 158529003) is 4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one.
What is the SMILES notation for 4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one?
The canonical SMILES for 4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one is C=C(C)c1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.C=C(CCCNc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12)OC.CC(C)CC1CC(=O)N(c2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)C1.Cc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.Cn1nc(N2CC(C)(C3CC3)CC2=O)c2ccc(Nc3n[nH]c4ccccc34)cc21.Cn1nc(N2CC(C)(C3CC3)CC2=O)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(N2CCCCC2)c2ccc(Nc3n[nH]c4cccnc34)cc21.
What is the InChIKey of 4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one?
The InChIKey is HNDDKPUNMVLOPY-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H24N6O.C22H23N7O.C22H25N7O.C20H23N7O.C19H21N7.C17H16N6.C15H14N6/c1-23(14-7-8-14)12-20(30)29(13-23)22-17-10-9-15(11-19(17)28(2)27-22)24-21-16-5-3-4-6-18(16)25-26-21;1-22(13-5-6-13)11-18(30)29(12-22)21-15-8-7-14(10-17(15)28(2)27-21)24-20-19-16(25-26-20)4-3-9-23-19;1-13(2)9-14-10-19(30)29(12-14)22-16-7-6-15(11-18(16)28(3)27-22)24-21-20-17(25-26-21)5-4-8-23-20;1-13(28-3)6-4-11-22-19-15-9-8-14(12-17(15)27(2)26-19)23-20-18-16(24-25-20)7-5-10-21-18;1-25-16-12-13(21-18-17-15(22-23-18)6-5-9-20-17)7-8-14(16)19(24-25)26-10-3-2-4-11-26;1-10(2)15-12-7-6-11(9-14(12)23(3)22-15)19-17-16-13(20-21-17)5-4-8-18-16;1-9-11-6-5-10(8-13(11)21(2)20-9)17-15-14-12(18-19-15)4-3-7-16-14/h3-6,9-11,14H,7-8,12-13H2,1-2H3,(H2,24,25,26);3-4,7-10,13H,5-6,11-12H2,1-2H3,(H2,24,25,26);4-8,11,13-14H,9-10,12H2,1-3H3,(H2,24,25,26);5,7-10,12H,1,4,6,11H2,2-3H3,(H,22,26)(H2,23,24,25);5-9,12H,2-4,10-11H2,1H3,(H2,21,22,23);4-9H,1H2,2-3H3,(H2,19,20,21);3-8H,1-2H3,(H2,17,18,19).
What are the key properties of 4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one?
4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one has a molecular weight of 2513.00 g/mol, XLogP of 26.11, 29 rotatable bonds, 15 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for 4-cyclopropyl-1-[6-(1H-indazol-3-ylamino)-1-methylindazol-3-yl]-4-methylpyrrolidin-2-one;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-prop-1-en-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one is sourced from PubChem (CID 158529003), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).